OXOS Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 70

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $10.7M

  • Investors
  • 12

OXOS General Information

Description

Developer of a digital imaging device designed for efficient and effective treatment of patients. The company's devices are fluoroscopic instruments used to convert radiation to real-time static and dynamic fluoroscopic images of the human skeleton, as well as provide high-quality digital pictures and video of surgical anatomy and pathology, enabling surgeons, doctors and healthcare providers to bring the x-ray source to the target to produce more resolute images.

Contact Information

Website
www.oxos.com
Formerly Known As
Micro C, The Micro C
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1100 Peachtree Street Northeast
  • Suite 700
  • Atlanta, GA 30309
  • United States
+1 (866)
Primary Industry
Diagnostic Equipment
Corporate Office
  • 1100 Peachtree Street Northeast
  • Suite 700
  • Atlanta, GA 30309
  • United States
+1 (866)

OXOS Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OXOS Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 12-Dec-2025 $10.7M Completed Generating Revenue
12. Later Stage VC (Series A1) 05-Apr-2023 Completed Generating Revenue
11. Later Stage VC (Series A) 26-Jan-2023 Completed Generating Revenue
10. Grant 14-Mar-2021 Completed Generating Revenue
9. Accelerator/Incubator 01-Jun-2020 Completed Generating Revenue
8. Seed Round 24-Feb-2021 Completed Generating Revenue
7. Debt - PPP 01-May-2020 Completed Generating Revenue
6. Seed Round 21-Feb-2020 Completed Generating Revenue
5. Angel (individual) 10-Jun-2018 $100K $4.05M Completed Startup
4. Seed Round 27-Feb-2018 $2.84M $3.95M Completed Startup
To view OXOS’s complete valuation and funding history, request access »

OXOS Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A-3
Series A-2
Seed-6
Seed-5
Seed-4
Seed-3
Seed-2 175,520 $0.000100 $3.73 $3.73 1x $3.73 1.39%
Seed-1 139,345 $0.000100 $1.87 $1.87 1x $1.87 1.1%
To view OXOS’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

OXOS Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a digital imaging device designed for efficient and effective treatment of patients. The company's devices
Diagnostic Equipment
Atlanta, GA
70 As of 2025

Waterloo, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OXOS Competitors (1)

One of OXOS’s competitors is KA Imaging, a Venture Capital-Backed company based in Waterloo, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
KA Imaging Venture Capital-Backed Waterloo, Canada
You’re viewing 1 of 1 competitors. Get the full list »

OXOS Patents

OXOS Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260051452-A1 X-ray tubes Pending 05-Apr-2024
US-11832976-B2 Imaging systems and methods Active 22-Mar-2022
US-12558043-B2 Imaging systems and methods Active 22-Mar-2022
US-20230301609-A1 Imaging systems and methods Active 22-Mar-2022
US-20230414185-A1 Imaging systems and methods Active 22-Mar-2022 A61B6/08
To view OXOS’s complete patent history, request access »

OXOS Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OXOS Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
BroadVision Group Venture Capital Minority
Chang Robotics Fund Venture Capital Minority
Seraph Group Venture Capital Minority
Intel Capital Corporate Venture Capital Minority
Parkway Venture Capital Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

OXOS FAQs

  • When was OXOS founded?

    OXOS was founded in 2016.

  • Where is OXOS headquartered?

    OXOS is headquartered in Atlanta, GA.

  • What is the size of OXOS?

    OXOS has 70 total employees.

  • What industry is OXOS in?

    OXOS’s primary industry is Diagnostic Equipment.

  • Is OXOS a private or public company?

    OXOS is a Private company.

  • What is OXOS’s current revenue?

    The current revenue for OXOS is .

  • How much funding has OXOS raised over time?

    OXOS has raised $56.7M.

  • Who are OXOS’s investors?

    BroadVision Group, Chang Robotics Fund, Seraph Group, Intel Capital, and Parkway Venture Capital are 5 of 12 investors who have invested in OXOS.

  • Who are OXOS’s competitors?

    KA Imaging is a competitor of OXOS.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process